Content by The Scientist

Are you a postdoctoral researcher with a passion for science and a desire for fame? We want to feature you!

Since the invention of the first vaccine over two centuries ago, new discoveries have emerged to confer better protection.

Christopher Gibbons from CND Life Sciences discusses how an emerging diagnostic tool is redefining early neurodegenerative disease detection and treatment strategies.

Björn Högberg explains how his team engineered a DNA origami nanorobot that activates only in tumors to trigger cancer cell death.

Scientists use spatial biology approaches to dissect molecular dynamics across tissues, organs, and subcellular compartments.

Ticks spread pathogenic infections, and surprisingly, immune reactions. New vaccine candidates may help reduce this risk. 

In the 150 years since chromosomes were first discovered, scientists have studied them in various contexts, from insect cells to artificial systems.

Benjamin Oakes from Scribe Therapeutics shares how exciting advancements in CRISPR-based gene and epigenetic editing therapies impact the future of cardiovascular and cardiometabolic disease management.

From chronic coughing to cancer, researchers have linked perfluoroalkyl and polyfluoroalkyl substance (PFAS) exposure to a growing list of health concerns.

Researchers and viticulturists seek a chemical-free future for New Zealand’s vineyards, supported by cost-effective next-generation sequencing technologies.

Steve Perrin from Eledon Pharmaceuticals shares how a novel immunosuppressive drug may improve outcomes for transplant recipients.

Parag Mallick from Nautilus Biotechnology discusses how new technology can power breakthroughs by unlocking the mysteries of the proteome.

Traci Degeer from Leica Biosystems highlights how modern techniques are charting a new course in cancer research and treatment.

Nikhil Rao from Syncell discusses how the Microscoop® optoproteomics platform enables unbiased proteomic exploration of disease-relevant sites.

Katherine Wilemon from the Family Heart Foundation discusses the importance of detecting high lipoprotein(a) levels to prevent adverse health consequences.